Metropolis Healthcare has notified the stock exchanges of a scheduled analyst and institutional investor meeting, pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated May 08, 2026, outlines the company's participation in an upcoming investor conference.

Investor Meeting Details

The meeting is scheduled to be held on May 27, 2026, as part of the 360 ONE Capital (B&K) Investor Conference. The following table summarises the key details of the interaction:

Disclosure and Compliance

Metropolis Healthcare has confirmed that all discussions during the meeting will be based on publicly available information. The company has explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction. The company has also noted that changes to the schedule may occur due to exigencies on the part of participants, the host, or the company itself.

The intimation has been filed by Kamlesh C Kulkarni, Head – Legal & Secretarial, and is available on the company's website at www.metropolisindia.com .

Metropolis Healthcare Limited has submitted its quarterly compliance certificate to stock exchanges for the quarter ended March 31, 2026, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The filing, dated April 07, 2026, confirms the company's adherence to prescribed dematerialisation processes and securities handling procedures.

Regulatory Compliance Certificate

The certificate was issued by MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, which serves as the company's Registrar and Transfer Agent. This document specifically addresses compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, covering the quarter ended March 31, 2026.

Dematerialisation Process Confirmation

The registrar confirmed that all securities received from depository participants for dematerialisation during the quarter were properly processed within prescribed timelines. The certificate validates that securities received for dematerialisation were appropriately confirmed or rejected to the depositories, with proper substitution of depository names in the member register.

Key aspects of the compliance confirmation include:

• Proper handling of securities received for dematerialisation
• Timely confirmation or rejection to depositories
• Appropriate mutilation and cancellation of physical certificates
• Substitution of depository names as registered owners within prescribed timelines

Filing Details and Authorization

The submission was authorized by Kamlesh C Kulkarni, Head – Legal & Secretarial at Metropolis Healthcare Limited, with digital signature authentication completed on April 07, 2026. The certificate from MUFG Intime India was signed by Ashok Shetty, Sr. Vice President-Corporate Registry, dated April 01, 2026.

This quarterly filing represents standard regulatory compliance for listed companies, ensuring transparency in securities handling and maintaining investor confidence in the dematerialisation process. The certificate confirms that all securities transactions during Q4FY26 were conducted in accordance with SEBI regulations and established market practices.